Kindred Healthcare, Inc. ("Kindred" or the "Company") (NYSE:KND) today announced that its Board of Directors approved the payment of a cash dividend of $0.12 per common share to its common shareholders. The dividend will be paid on December 9, 2016 to common shareholders of record as of the close of business on November 21, 2016. Kindred also today announced that its Board of Directors has approved payment in cash of the scheduled December 1, 2016 installment payment of $18.75 per share of the Company's Mandatory Redeemable Preferred Stock, Series A. The installment payment will be paid on December 1, 2016 to the preferred shareholders of record as of 5:00 p.m., New York City time, on November 15, 2016. Future declarations of dividends and installment payments will be subject to the approval of Kindred's Board of Directors. Forward-Looking Statements This press release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, all statements regarding the Company's ability to exit the skilled nursing facility business, as well as the Company's ability to realize the anticipated benefits, cost savings and strategic gains from this initiative, all statements regarding the Company's expected future financial position, results of operations, cash flows, dividends, financing plans, business strategy, budgets, capital expenditures, competitive positions, growth opportunities, plans and objectives of management, government investigations, regulatory matters, and statements containing words such as "anticipate," "approximate," "believe," "plan," "estimate," "expect," "project," "could," "would," "should," "will," "intend," "may," "potential," "upside," and other similar expressions. Statements in this press release concerning the Company's business outlook or future economic performance, anticipated profitability, revenues, expenses, dividends or other financial items, product or services line growth, and expected outcome of government investigations and other regulatory matters, together with other statements that are not historical facts, are forward-looking statements that are estimates reflecting the best judgment of the Company based upon currently available information.